{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:42:49Z","timestamp":1792204969722,"version":"4.4.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To determine whether locally injected tranexamic acid (TXA) used in the surgical treatment of fragility hip fractures can lower transfusion rates without increasing the risk of complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Retrospective comparative cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Tertiary referral orthopaedic specialty hospital, Level I trauma center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients\/Participants:<\/jats:title>\n            <jats:p>A total of 490 patients (252 patients received TXA) 50 years of age and older who underwent surgery for a low-energy fragility fracture of the proximal femur between March 2018 and February 2020 were included in this study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Intervention:<\/jats:title>\n            <jats:p>Use of locally injected TXA at the time of wound closure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main Outcome:<\/jats:title>\n            <jats:p>The main outcomes of this study were the number of patients requiring postoperative blood transfusions, incidences of venous thromboembolism, and surgical site infections.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A statistically significant difference was noted in the frequency of transfusion between patients who received TXA compared with those who did not receive TXA (33% vs. 43%, respectively) (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.034). There were no significant differences in venous thromboembolism incidence (0.4% vs. 0.8% TXA vs. No TXA) (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.526) or infections (0.4% vs. 0.4% TXA vs. No TXA) (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.965). Regression analysis indicated that the use of TXA reduced the need for postoperative blood transfusion by 31% (odds ratio: 0.688, 95% CI: 0.477\u20130.993, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.045).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Locally injected TXA significantly reduced the need for postoperative transfusion in the surgical treatment of fragility hip fractures. In addition, there was no increased risk of complications in those receiving TXA versus those who did not. Locally injected TXA seems to be both a safe and effective way to reduce postoperative blood transfusions in patients with fragility hip fractures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Level of Evidence:<\/jats:title>\n            <jats:p>Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bot.0000000000002241","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T16:10:18Z","timestamp":1628871018000},"page":"147-151","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and Safety of Locally Injected Tranexamic Acid in Hip Fracture Patients: A Retrospective Review"],"prefix":"10.1097","volume":"36","author":[{"given":"Daniel","family":"Witmer","sequence":"first","affiliation":[{"name":"Orthopedic Associates of Hartford, Hartford, CT; and"},{"name":"Bone and Joint Institute, Hartford Hospital, Hartford Healthcare, Hartford, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Solomito","sequence":"additional","affiliation":[{"name":"Bone and Joint Institute, Hartford Hospital, Hartford Healthcare, Hartford, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Kumar","sequence":"additional","affiliation":[{"name":"Bone and Joint Institute, Hartford Hospital, Hartford Healthcare, Hartford, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Shearier","sequence":"additional","affiliation":[{"name":"Bone and Joint Institute, Hartford Hospital, Hartford Healthcare, Hartford, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Davis","sequence":"additional","affiliation":[{"name":"Orthopedic Associates of Hartford, Hartford, CT; and"},{"name":"Bone and Joint Institute, Hartford Hospital, Hartford Healthcare, Hartford, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jot.2019.03.007","article-title":"The efficacy and safety of intravenous tranexamic acid in hip fracture surgery: a systematic review and meta-analysis","volume":"19","author":"Qi","year":"2019","journal-title":"J Orthop Translat."},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/os.12511","article-title":"Efficacy and safety of tranexamic acid in intertrochanteric fractures: a single-blind randomized controlled trial","volume":"11","author":"Zhou","year":"2019","journal-title":"Orthop Surg."},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"e010676","DOI":"10.1136\/bmjopen-2015-010676","article-title":"Tranexamic acid in hip fracture patients: a protocol for a randomised, placebo controlled trial on the efficacy of tranexamic acid in reducing blood loss in hip fracture patients","volume":"6","author":"Gausden","year":"2016","journal-title":"BMJ Open"},{"key":"R4-20250614","first-page":"945","article-title":"Hip fracture: diagnosis, treatment, and secondary prevention","volume":"89","author":"Leblanc","year":"2014"},{"key":"R5-20250614","first-page":"120","article-title":"Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trial","volume":"25","author":"Chen","year":"2019","journal-title":"Hong Kong Med J."},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1111\/bcp.13079","article-title":"A systematic review of tranexamic acid in hip fracture surgery","volume":"82","author":"Farrow","year":"2016","journal-title":"Br J Clin Pharmacol."},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.injury.2010.02.015","article-title":"The hidden blood loss after hip fracture","volume":"42","author":"Smith","year":"2011","journal-title":"Injury"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13018-017-0625-9","article-title":"Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial","volume":"12","author":"Lei","year":"2017","journal-title":"J Orthop Surg Res."},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0033-3506(05)80614-6","article-title":"What is the true mortality of hip fractures?","volume":"105","author":"Parker","year":"1991","journal-title":"Public Health"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/BOT.0000000000000919","article-title":"Efficacy and safety of tranexamic acid in orthopaedic fracture surgery: a meta-analysis and systematic literature review","volume":"31","author":"Amer","year":"2017","journal-title":"J Orthop Trauma."},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1182\/blood-2008-10-167643","article-title":"Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention","volume":"113","author":"Vamvakas","year":"2009","journal-title":"Blood"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.arth.2016.08.026","article-title":"Allogeneic blood transfusion is a significant risk factor for surgical-site infection following total hip and knee arthroplasty: a meta-analysis","volume":"32","author":"Kim","year":"2017","journal-title":"J Arthroplasty"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.arth.2012.04.024","article-title":"Tranexamic acid for reduction of blood loss during total hip arthroplasty","volume":"27","author":"Imai","year":"2012","journal-title":"J Arthroplasty"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.arth.2014.08.022","article-title":"Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty","volume":"30","author":"Duncan","year":"2015","journal-title":"J Arthroplasty"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.arth.2014.03.011","article-title":"Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study","volume":"29","author":"Patel","year":"2014","journal-title":"J Arthroplasty"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.arth.2013.06.011","article-title":"Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty","volume":"28","author":"Konig","year":"2013","journal-title":"J Arthroplasty"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.arth.2016.07.004","article-title":"Intravenous vs intra-articular tranexamic acid in total knee arthroplasty: a randomized, double-blind trial","volume":"32","author":"Goyal","year":"2017","journal-title":"J Arthroplasty"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13018-017-0520-4","article-title":"Combined use of intravenous and topical versus intravenous tranexamic acid in primary total knee and hip arthroplasty: a meta-analysis of randomised controlled trials","volume":"12","author":"Li","year":"2017","journal-title":"J Orthop Surg Res."},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/TA.0000000000002061","article-title":"Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism","volume":"86","author":"Myers","year":"2019","journal-title":"J Trauma Acute Care Surg."},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1302\/0301-620X.103B3.BJJ-2021-0172","article-title":"Infographic: single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial","volume":"103","author":"Nikolau","year":"2021","journal-title":"Bone Joint J."}],"container-title":["Journal of Orthopaedic Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000002241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T19:01:30Z","timestamp":1749927690000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000002241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/bot.0000000000002241","relation":{},"ISSN":["0890-5339"],"issn-type":[{"value":"0890-5339","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"2021-08-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}